multipl
sclerosi
ms
chronic
demyelin
patholog
central
nervou
system
present
seriou
medic
social
problem
etiolog
remain
unclear
valid
theori
pathogenesi
assign
main
role
destruct
myelinproteolipid
shell
axon
inflamm
relat
autoimmun
reaction
ref
therein
although
tcell
immun
system
play
lead
role
ms
pathogenesi
normal
function
bcell
system
also
import
diseas
develop
enhanc
synthesi
immunoglobulin
usual
igg
free
light
chain
polyspecif
dna
bind
antibodi
ab
interact
phospholipid
observ
ms
patient
new
key
understand
ms
pathogenesi
appear
clone
igg
repertoir
directli
activ
plaqu
periplaqu
region
ms
brain
bcell
recov
cerebrospin
fluid
patient
ms
subacut
diseas
found
high
affin
antidna
ab
major
compon
intrathec
igg
respons
ms
patient
furthermor
dnaspecif
monoclon
ab
deriv
two
ms
individu
well
dnaspecif
ab
deriv
system
lupu
erythematosu
sle
patient
bound
effici
surfac
neuron
cell
oligodendrocyt
ab
cellsurfac
recognit
dnadepend
find
indic
antidna
ab
may
promot
import
neuropatholog
mechan
chronic
inflammatori
disord
ms
sle
artifici
abzym
catalyt
antibodi
transit
state
analogu
chemic
reaction
natur
abzym
novel
biolog
catalyst
attract
much
interest
last
year
review
artifici
abzym
abzym
analog
transit
state
catalyt
reaction
antiidiotyp
ab
induc
primari
antigen
may
show
featur
includ
catalyt
activ
review
also
see
past
two
decad
becom
clear
autoantibodi
autoab
sera
patient
differ
autoimmun
diseas
possess
enzymat
activ
occurr
distinct
featur
autoimmun
diseas
review
thought
abzym
may
play
signific
role
form
specif
pathogen
pattern
clinic
set
differ
autoimmun
condit
broaden
autoab
properti
patient
autoimmun
diseas
produc
ab
nucleoprotein
complex
dna
enzym
particip
nucleic
acid
metabol
autoimmun
diseas
spontan
induct
antiidiotyp
antibodi
ab
elicit
primari
antigen
includ
catalyt
activ
transit
polyreact
catalyt
activ
autoantigendirect
activ
natur
abzym
hydrolyz
dna
rna
polysaccharid
oligopeptid
protein
present
serum
patient
sever
autoimmun
viral
diseas
review
healthi
human
develop
abzym
detect
dnase
rnase
activ
level
usual
borderlin
sensit
detect
method
recent
shown
myelin
basic
protein
mbp
hydrolyz
activ
intrins
properti
igg
igm
iga
sera
ms
patient
recognit
degrad
mbp
peptid
serum
autoab
confirm
novel
biomark
ms
establish
ms
drug
copaxon
appear
specif
inhibitor
mbphydrolyz
abzym
activ
time
mention
antidna
ab
found
major
compon
intrathec
igg
respons
ms
patient
first
dnase
abzym
found
sera
sle
patient
shown
igg
igm
sera
ms
patient
effect
hydrolyz
dna
rna
oligosaccharid
wherea
ms
patient
contain
increas
concentr
ab
nativ
denatur
dna
respect
compar
healthi
donor
dnase
abzym
found
ms
patient
sinc
dnase
abzym
ms
patient
similarli
sle
patient
cytotox
caus
nuclear
dna
fragment
induc
cell
death
apoptosi
play
import
role
sle
ms
pathogenesi
take
observ
account
analysi
rel
concentr
protein
canon
enzym
dnase
abzym
cerebrospin
fluid
csf
ms
patient
special
interest
present
studi
use
differ
approach
provid
first
time
strong
direct
evid
dnase
activ
intrins
igg
csf
ms
patient
compar
paramet
character
ms
csf
sera
fifteen
patient
women
men
satisfi
criteria
clinic
laboratorysupport
definit
ms
accord
retrospect
select
studi
rr
primari
progress
pp
agreement
criteria
lublin
reingold
clinic
cours
rr
pp
clinic
activ
relaps
time
sampl
mri
activ
presenc
gadolinium
enhanc
lesion
mri
examin
analyz
describ
previous
characterist
ms
patient
summar
tabl
interest
compar
differ
index
csf
sera
ms
patient
therefor
first
measur
rel
concentr
total
protein
csf
sera
ms
patient
tabl
rel
concentr
total
protein
csf
rang
mgml
sera
mgml
fifteen
ms
patient
vari
differ
rang
averag
concentr
total
protein
serum
mgml
higher
compar
csf
mgml
valu
demonstr
good
correl
coeffici
correl
cc
tabl
rel
concentr
total
igg
serum
csf
first
measur
use
immunoblot
test
system
rel
concentr
total
igg
serum
rang
mgml
averag
valu
mgml
higher
csf
rang
mgml
averag
valu
mgml
good
correl
valu
cc
igg
serum
csf
purifi
affin
chromatographi
prote
sepharos
iggprotein
concentr
estim
peak
elut
sorbent
acid
buffer
see
rel
concentr
total
igg
determin
two
differ
method
within
experiment
error
interestingli
concentr
total
protein
csf
higher
total
igg
differ
case
serum
factor
lower
estim
rel
concentr
antidna
antibodi
csf
serum
rel
concentr
antidna
antibodi
csf
patient
measur
dilut
csf
valu
csf
compar
rang
unit
count
cerebrospin
fluid
without
dilut
averag
valu
unit
case
serum
dilut
significantli
vari
rang
unit
count
serum
without
dilut
averag
valu
unit
sinc
rel
concentr
antidna
antibodi
csf
rel
low
remov
ab
csf
passag
two
column
protein
gsepharos
protein
asepharos
csf
pass
column
control
contain
standard
buffer
demonstr
valu
comparison
untreat
csf
thu
shown
rel
low
valu
correspond
untreat
csf
caus
antidna
antibodi
csf
addit
shown
dnahydrolyz
activ
intrins
properti
igg
csf
see
good
correl
antidna
antibodi
sera
csf
cc
tabl
addit
correl
low
total
concentr
igg
antidna
antibodi
csf
cc
serum
cc
time
averag
differ
concentr
total
igg
serum
csf
lower
differ
antidna
antibodi
serum
csf
tabl
known
human
sera
contain
sever
major
especi
minor
protein
averag
concentr
total
protein
serum
higher
csf
tabl
interest
compar
major
protein
sera
csf
use
sd
polyacrylamid
gel
electrophoresi
sdspage
fig
demonstr
major
protein
sampl
sera
csf
one
see
sera
contain
major
protein
case
igg
kda
human
serum
albumin
kda
major
protein
time
contrast
csf
sera
contain
sever
major
protein
mol
mass
higher
kda
well
lower
kda
higher
kda
fig
interest
see
csf
sever
addit
good
visibl
protein
electrophoret
mobil
lower
kda
comparison
serum
prepar
interest
compar
total
dnase
rel
activ
ra
dnahydrolyz
enzym
ab
sera
csf
ms
patient
prepar
total
protein
capabl
hydrolyz
supercoil
plasmid
dna
scdna
form
singl
break
one
strand
supercoil
dna
relax
dna
multipl
break
yield
linear
dna
final
hydrolyz
dna
short
mediumlength
oligonucleotid
howev
deep
hydrolysi
dna
difficult
estim
rel
activ
prepar
ra
total
protein
sera
csf
vari
remark
patient
patient
fig
illustr
typic
exampl
cleavag
scdna
total
protein
sever
ms
patient
h
incub
therefor
order
estim
dnase
activ
quantit
found
concentr
prepar
time
incub
suffici
convert
scdna
relax
form
exampl
lane
fig
without
notic
fragment
h
incub
sinc
measur
initi
rate
taken
within
linear
region
time
cours
protein
concentr
measur
ra
normal
standard
condit
pmole
mg
h
standard
unit
su
tabl
rel
specif
dnase
activ
total
protein
serum
prepar
vari
rang
pmole
mg
h
averag
valu
su
surpris
specif
activ
total
protein
csf
repar
higher
rang
su
averag
valu
su
serum
one
tabl
time
concentr
total
protein
case
csf
lower
sera
tabl
therefor
calcul
ml
liquid
averag
ra
total
protein
correspond
sera
lower
csf
recent
sever
strict
criteria
appli
show
dnase
activ
intrins
properti
igg
sera
ms
patient
healthi
donor
search
abzym
csf
ms
patient
igg
fraction
purifi
chromatographi
proteina
sepharos
condit
remov
nonspecif
bound
protein
follow
gelfiltr
rel
amount
csf
prepar
thirteen
ms
patient
enough
purif
igg
prepar
analyz
averag
situat
ms
igg
prepar
mixtur
equal
amount
igg
sera
thirteen
patient
iggmix
homogen
kda
iggmix
confirm
sdspage
show
singl
band
two
band
correspond
h
l
chain
ab
reduct
dtt
silver
stain
fig
prove
dnase
activ
csf
iggmix
intrins
properti
due
copurifi
enzym
appli
well
known
rigid
criteria
electrophoret
homogen
iggmix
fig
b
gelfiltr
iggmix
condit
acid
shock
ph
lead
disappear
ab
activ
peak
activ
track
exactli
kda
ab
fig
c
complet
adsorpt
activ
sepharos
bear
monoclon
mous
ab
human
igg
light
chain
elut
adsorb
buffer
low
ph
fig
order
exclud
possibl
artifact
due
hypothet
trace
contamin
enzym
analyz
addit
dnase
activ
iggmix
use
situ
assay
sdspage
gel
contain
dna
incub
order
allow
dnase
renatur
stain
ethidium
bromid
sharp
dark
band
posit
dna
hydrolyz
protein
reveal
fluoresc
background
dnabound
ethidium
bromid
fig
dissoci
iggmix
use
dtt
dnase
activ
reveal
band
separ
light
chain
similar
data
obtain
earlier
abzym
serum
ms
patient
sinc
sd
dissoci
protein
complex
electrophoret
mobil
hypothet
contamin
dnase
coincid
time
intact
igg
lchain
detect
dnase
activ
gel
region
correspond
igg
light
chain
togeth
absenc
band
activ
protein
provid
direct
evid
dnase
activ
intrins
properti
ms
iggmix
due
copurifi
enzym
dnase
activ
detect
earlier
case
igg
sera
ms
patient
none
healthi
donor
possibl
get
csf
prepar
healthi
donor
howev
one
assum
csf
similarli
serum
prepar
healthi
donor
contain
igg
dnase
activ
compar
ra
hydrolysi
dna
igg
prepar
sera
csf
thirteen
ms
patient
ra
igg
sera
csf
vari
markedli
patient
patient
fig
illustr
typic
exampl
cleavag
scdna
igg
mgml
sera
csf
mgml
sever
patient
h
incub
fix
concentr
estim
dnase
activ
quantit
found
concentr
igg
prepar
correspond
linear
part
rate
depend
ab
concentr
condit
reaction
pseudofirst
order
time
incub
suffici
convert
scdna
relax
form
without
fragment
h
incub
dna
hydrolysi
linear
rang
time
cours
exampl
lane
fig
sinc
measur
initi
rate
taken
within
linear
region
time
cours
ab
concentr
curv
measur
ra
individu
igg
normal
standard
condit
similarli
prepar
total
protein
tabl
surpris
csf
igg
possess
significantli
higher
specif
dnase
activ
serum
one
averag
specif
dnase
activ
serum
igg
averag
valu
pmole
mg
h
rang
unit
lower
csf
ab
averag
valu
unit
rang
unit
tabl
time
good
correl
catalyt
activ
igg
sera
csf
cc
tabl
interestingli
averag
specif
ra
serum
igg
higher
serum
total
protein
differ
case
csf
significantli
lower
tabl
publish
data
concern
csf
abzym
catalyt
activ
data
report
paper
provid
strong
evid
dnase
activ
intrins
properti
igg
present
csf
ms
patient
due
copurifi
enzym
presenc
antidna
ab
dnase
igg
csf
ms
patient
agreement
detect
bcell
produc
antidna
ab
directli
activ
plaqu
periplaqu
region
ms
brain
cerebrospin
fluid
patient
ms
sinc
sera
ms
patient
contain
greater
number
differ
protein
csf
fig
averag
concentr
total
protein
sera
higher
csf
surpris
averag
specif
ra
csf
total
protein
higher
serum
one
question
specif
ra
csf
total
igg
significantli
activ
sera
addit
rel
concentr
ab
total
pool
interact
dna
sera
higher
csf
differ
concentr
total
igg
differ
tabl
thu
small
specif
fraction
antidna
ab
csf
may
activ
total
similar
small
fraction
ab
interact
dna
sera
context
data
literatur
mention
overal
abzym
ms
patient
may
significantli
activ
hydrolysi
dna
found
tabl
previous
shown
fraction
abzym
differ
catalyt
activ
includ
nucleas
one
serum
autoimmun
patient
usual
exceed
total
immunoglobulin
sinc
specif
activ
calcul
use
total
concentr
igg
specif
dnase
activ
individu
monoclon
subfract
polyclon
igg
pool
may
significantli
higher
nonfraction
igg
addit
repertoir
polyclon
ab
differ
antigen
case
sera
ms
patient
may
significantli
wider
csf
may
one
possibl
reason
lower
specif
activ
sera
igg
time
evergrow
number
observ
suggest
autoimmun
diseas
origin
defect
hematopoiet
stem
cell
recent
shown
specif
reorgan
immun
system
spontan
develop
profound
slelik
patholog
mrllprlpr
mice
associ
chang
differenti
profil
level
prolifer
bone
marrow
hematopoiet
stem
cell
product
dnase
atpas
amylas
abzym
immun
healthi
mice
dna
also
lead
product
ab
dnase
activ
howev
associ
increas
lymphocyt
prolifer
suppress
apoptosi
lymphocyt
differ
organ
especi
spleen
chang
differenti
bone
marrow
cell
thu
reason
suggest
bcell
csf
ms
patient
produc
ab
interact
dna
also
specif
antidna
abzym
higher
dnase
activ
abzym
produc
lymphocyt
dna
differ
organ
ms
patient
circul
blood
system
may
lower
dnase
activ
comparison
antidna
ab
csf
may
differ
ratio
abzym
antidna
ab
without
catalyt
activ
csf
sera
ms
patient
estim
cc
differ
characterist
csf
sera
shown
good
correl
sever
ident
index
character
csf
sera
ms
patient
cc
vari
rang
tabl
correl
total
protein
concentr
total
concentr
igg
csf
cc
column
sera
cc
column
b
rel
concentr
antidna
ab
csf
cc
column
sera
cc
column
low
tabl
time
low
still
best
posit
correl
observ
total
protein
concentr
rel
dnase
activ
total
csf
protein
cc
column
wherea
sera
valu
show
neg
correl
cc
column
tabl
similar
low
cc
observ
estim
paramet
cc
rel
concentr
igg
antidna
ab
rel
low
csf
cc
column
neg
sera
cc
column
tabl
interestingli
cc
concentr
igg
rel
specif
dnase
activ
csf
ab
cc
column
lower
sera
cc
column
tabl
final
rel
concentr
total
antidna
ab
correl
rel
specif
igg
dnase
activ
better
sera
cc
column
csf
cc
column
tabl
addit
question
good
correl
variou
index
character
differ
ms
patient
analysi
correl
titer
ab
dna
well
mbp
differ
standard
clinic
paramet
includ
poser
criteria
index
evalu
damag
function
system
pyramid
function
cerebellar
function
function
brain
stem
sensit
function
function
intestin
urinari
bladder
visual
function
cerebr
psychic
function
sum
characterist
case
patient
ms
carri
whole
group
ms
patient
absolut
valu
posit
cc
titer
antidna
antimbp
ab
clinic
poser
index
low
absent
even
neg
statist
nonsignific
sever
cc
becam
higher
reach
valu
divis
cohort
subgroup
patient
primari
progress
secondari
progress
remit
cours
diseas
group
primari
progress
remit
cours
secondari
progress
cours
ms
patient
homogen
respect
patient
characterist
subdivis
use
cluster
factori
analysi
reveal
high
statist
signific
correl
coeffici
exampl
one
subsubgroup
remit
cours
subgroup
direct
depend
titer
antimbp
symptom
lesion
pyramid
tract
observ
cc
case
correl
opposit
sign
observ
pair
analyz
paramet
three
subgroup
differ
ms
cours
subsubgroup
obtain
cluster
analysi
subgroup
absenc
definit
depend
titer
antidna
antimbp
ab
paramet
standard
clinic
indic
may
due
sever
reason
ms
extrem
multifactori
diseas
similar
pathomorpholog
clinic
indic
manifest
ms
may
result
differ
underli
process
condit
exampl
ms
patient
rel
stabil
differ
organ
function
destruct
effect
transient
immun
system
error
significantli
differ
depend
genet
background
environment
stress
factor
includ
geograph
one
protein
influenza
herp
polyoma
virus
bacteria
report
mimic
human
myelin
protein
infect
therefor
lead
immun
protein
stimul
subsequ
format
ab
myelin
final
develop
autoimmun
reaction
individu
ms
patient
develop
autoimmun
reaction
stimul
differ
viral
bacteri
infect
well
variou
toxic
chemic
furthermor
also
taken
account
ms
patholog
least
two
phase
cascad
reaction
correspond
first
inflammatori
phase
complic
involv
mani
protein
enzym
cytokin
chemokin
induc
macrophag
cell
produc
radic
osteopathin
complex
coordin
action
bcell
complement
system
inflamm
mediat
autoab
result
format
demyelin
nodi
interrupt
axon
conduct
neurodegen
phase
ms
ensu
later
directli
connect
neural
tissu
destruct
patient
therefor
analysi
biochem
immunolog
clinic
indic
must
take
account
current
stage
diseas
obvious
quit
differ
characterist
patholog
process
obtain
individu
patient
diseas
progress
background
continu
chang
immunoregul
includ
exhaust
differ
compensatori
adapt
mechan
system
metabol
chang
make
clinic
cours
ms
hardli
predict
individu
patient
therefor
surpris
could
find
high
statist
signific
correl
titer
ab
dna
ra
abzym
paramet
measur
sinc
patient
character
individu
combin
genet
environment
chronic
inflammatori
autoimmun
demyelin
neurodegen
factor
overal
data
obtain
demonstr
dnase
activ
intrins
properti
igg
deriv
csf
sera
ms
patient
igg
polyclon
may
consist
extrem
differ
repertoir
dnase
subfract
case
csf
sera
shown
previous
appear
abzym
specif
hydrolyz
dna
among
earliest
clear
sign
autoimmun
reaction
number
autoimmun
diseas
titr
ab
dna
autoantigen
yet
increas
significantli
correspond
rang
healthi
donor
therefor
detect
dnase
ab
sera
csf
peopl
consid
addit
index
earli
diagnost
patholog
chemic
protein
protein
gsepharos
superdex
hr
column
sigma
ge
healthcar
fifteen
consecut
ms
patient
women
men
mean
age
year
satisfi
criteria
definit
ms
accord
classif
mcdonald
admit
multipl
sclerosi
center
univers
ferrara
period
januari
octob
retrospect
select
studi
diseas
sever
score
ms
patient
time
sampl
collect
use
kurtzk
expand
disabl
statu
scale
edss
mean
entri
rang
clinic
cours
rr
pp
clinic
activ
relaps
time
sampl
mri
activ
presenc
gadolinium
enhanc
lesion
mri
examin
analyz
describ
previous
entri
none
patient
fever
symptom
sign
acut
infect
moreov
time
sampl
collect
none
patient
receiv
potenti
diseasemodifi
therapi
month
studi
blood
csf
sampl
protocol
confirm
local
committe
medic
ethic
research
comitato
etico
della
provincia
di
ferrara
approv
studi
accord
helsinki
ethic
committe
guidelin
includ
written
consent
patient
confin
present
blood
csf
diagnost
possibl
diseas
scientif
purpos
protocol
approv
may
focus
creation
biolog
bank
csf
serum
sampl
relat
clinic
data
patient
ms
neurolog
diseas
includ
studi
potenti
marker
especi
protein
diagnost
prognost
signific
diseas
nervou
system
b
specif
antibodi
direct
antigen
potenti
exogen
andor
endogen
c
presenc
pathogen
mostli
virus
bacteria
associ
studi
pathogenesi
neurotransmitt
metabolit
e
studi
differ
properti
differ
marker
csf
serum
sampl
collect
steril
condit
store
aliquot
assay
cellfre
csf
sampl
obtain
centrifug
room
temperatur
specimen
taken
atraumat
lumbar
punctur
perform
purpos
diagnosi
absenc
contraind
serum
sampl
deriv
centrifug
blood
specimen
withdrawn
punctur
anterocubit
vein
time
csf
extract
pair
csf
serum
sampl
ms
patient
store
measur
exactli
condit
inform
consent
given
patient
inclus
studi
design
approv
region
committe
medic
ethic
research
csf
serum
igg
level
measur
immunochem
nephelometri
beckman
immag
immunochemistri
system
beckman
instrument
inc
fullerton
ca
usa
accord
procedur
salden
et
al
case
protein
concentr
intact
csf
sera
ms
patient
final
solut
ab
measur
use
bradford
assay
bovin
serum
albumin
standard
concentr
igg
purif
affin
chromatographi
protein
gsepharos
see
measur
way
rel
concentr
igg
intact
csf
sera
ms
patient
analyz
use
special
quantit
isoelectrofocus
immunoblot
test
system
itali
accord
standard
manufactur
protocol
equip
igg
ief
helena
laboratori
gateshead
tyne
wear
uk
addit
rel
concentr
igg
intact
csf
sera
ms
patient
measur
ab
purif
affin
chromatographi
protein
gsepharos
see
titer
antidna
ab
determin
use
standard
assay
plate
immobil
doublestrand
dna
horseradish
peroxidaseconjug
mous
ab
human
igg
tetraethyl
benzidin
substrat
accord
standard
manufactur
protocol
vector
russia
prepar
human
blood
serum
csf
dilut
respect
time
final
solut
ad
strip
reaction
stop
sulphur
acid
optic
densiti
solut
determin
use
uniskan
ii
plate
reader
mtx
lab
system
usa
rel
concentr
antidna
ab
sampl
express
differ
rel
absorb
nm
averag
three
measur
experiment
sampl
control
sampl
contain
ab
addit
control
use
prepar
complet
devoid
ab
passag
csf
protein
gsepharos
protein
asepharos
differ
rel
absorb
nm
csf
prepar
contain
ab
control
contain
buffer
final
valu
recalcul
respect
biolog
fluid
without
dilut
electrophoret
immunolog
homogen
igg
obtain
sequenti
affin
chromatographi
csf
serum
protein
protein
gsepharos
fplc
gel
filtrat
similarli
case
protein
correspond
central
part
igg
peak
concentr
use
purif
analysi
igg
csf
incub
mm
glycinehcl
ph
contain
nacl
min
separ
igg
acid
shock
condit
done
fplc
gel
filtrat
superdex
hr
column
equilibr
mm
glycinehcl
ph
contain
nacl
previous
describ
week
storag
order
refold
acid
shock
ab
use
activ
assay
describ
case
electrophoret
homogen
igg
chromatograph
sepharos
bear
immobil
monoclon
mous
ab
light
chain
human
igg
protein
appli
column
ml
equilibr
mm
trishcl
ph
contain
nacl
column
wash
buffer
contain
nacl
ab
elut
glycinehcl
ph
neutral
dialyz
steril
describ
dnahydrolyz
activ
total
protein
igg
prepar
analyz
use
supercoil
sc
dna
earlier
describ
analysi
dnase
human
serum
catalyt
antibodi
reaction
mixtur
contain
scdna
pbluescript
mm
mm
edta
mm
trishcl
ph
mgml
ab
initi
prepar
sera
csf
total
protein
final
dilut
respect
reaction
mixtur
incub
h
standard
time
h
cleavag
product
analyz
electrophoresi
agaros
gel
imag
ethidium
bromidestain
gel
captur
soni
camera
rel
amount
dna
differ
band
analyz
use
imagequ
molecular
dynam
activ
igg
prepar
determin
decreas
percentag
dna
convert
initi
supercoil
form
relax
form
correct
distribut
dna
band
control
incub
pbluescript
absenc
ab
measur
initi
rate
taken
within
linear
region
time
cours
dna
hydrolysi
recalcul
standard
condit
see
tabl
sdspage
analysi
ab
homogen
polypeptid
spectrum
sera
csf
perform
gradient
gel
contain
sd
laemmli
system
describ
igg
use
treatment
mm
dithiothreitol
polypeptid
visual
silver
coomassi
blue
stain
situ
experi
dnase
activ
igg
sdspage
analyz
gel
contain
calf
thymu
dna
nonreduc
condit
electrophoresi
igg
sampl
incub
min
mm
trishcl
ph
contain
sd
restor
enzymat
activ
sdspage
sd
remov
incub
gel
h
mm
trishcl
ph
wash
gel
five
time
buffer
refold
protein
sd
treatment
assay
dnase
activ
longitudin
slice
gel
incub
h
reaction
buffer
contain
mm
trishcl
ph
mm
mm
visual
product
dna
hydrolysi
gel
stain
ethidium
bromid
ethidium
bromidestain
parallel
longitudin
slice
use
detect
posit
igg
gel
coomassi
blue
stain
result
report
mean
se
least
three
independ
experi
sampl
analyz
error
valu
within
correl
coeffici
cc
set
differ
sampl
analyz
